Research Letter: Anticholinergic Drugs and the Gallbladder -A Neglected Effect?
- PMID: 28488984
- PMCID: PMC5424598
- DOI: 10.7812/TPP/16-133
Research Letter: Anticholinergic Drugs and the Gallbladder -A Neglected Effect?
Conflict of interest statement
The author(s) have no conflicts of interest to disclose.
Comment on
-
Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.Cancer Causes Control. 2009 Dec;20(10):1821-35. doi: 10.1007/s10552-009-9375-2. Cancer Causes Control. 2009. PMID: 19582585 Free PMC article. Review.
References
-
- Friedman GD, Udaltsova N, Chan J, Quesenberry CP, Jr, Habel LA. Screening pharmaceuticals for possible carcinogenic effects: Initial positive results for drugs not previously screened. Cancer Causes Control. 2009 Dec;20(10):1821–35. DOI: https://doi.org/10.1007/s10552-009-9375-2. - DOI - PMC - PubMed
-
- Ditropan (oxybutynin chloride) tablets [Internet] Silver Spring, MD: US Food and Drug Administration; 2009. Jul 23, [cited 2016 Sep 30]. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2009/017577s035lbl.pdf.
-
- Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg. 1993 Apr;165(4):399–404. DOI: https://doi.org/10.1016/s0002-9610(05)80930-4. - DOI - PubMed
-
- Erlinger S. Drug-induced cholestasis. J Hepatol. 1997;26( Suppl 1):1–4. DOI: https://doi.org/10.1016/s0168-8278(97)82326-4. - DOI - PubMed
-
- Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver. 2012 Apr;6(2):172–87. DOI: https://doi.org/10.5009/gnl.2012.6.2.172. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
